Počet záznamů: 1  

Statins do not inhibit the FGFR signaling in chondrocytes

  1. 1.
    SYSNO ASEP0480628
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevStatins do not inhibit the FGFR signaling in chondrocytes
    Tvůrce(i) Fafílek, B. (CZ)
    Hampl, Marek (UZFG-Y) ORCID
    Říčánková, N. (CZ)
    Veselá, Iva (UZFG-Y)
    Bálek, L. (CZ)
    Kunová Bosáková, M. (CZ)
    Gudernová, I. (CZ)
    Vařecha, M. (CZ)
    Buchtová, Marcela (UZFG-Y) RID, ORCID
    Krejčí, P. (CZ)
    Zdroj.dok.Osteoarthritis and Cartilage. - : Elsevier - ISSN 1063-4584
    Roč. 25, č. 9 (2017), s. 1522-1530
    Poč.str.9 s.
    Forma vydáníTištěná - P
    Jazyk dok.eng - angličtina
    Země vyd.GB - Velká Británie
    Klíč. slovastatins ; FGF signaling ; chondrocytes
    Vědní obor RIVEB - Genetika a molekulární biologie
    Obor OECDDevelopmental biology
    CEPGA14-31540S GA ČR - Grantová agentura ČR
    Institucionální podporaUZFG-Y - RVO:67985904
    UT WOS000407934000019
    EID SCOPUS85020752812
    DOI10.1016/j.joca.2017.05.014
    AnotaceObjective: Statins are widely used drugs for cholesterol lowering, which were recently found to counteract the effects of aberrant fibroblast growth factor receptor (FGFR3) signaling in cell and animal models of FGFR3-related chondrodysplasia. This opened an intriguing therapeutic possibility for human dwarfing conditions caused by gain-of-function mutations in FGFR3, although the mechanism of statin action on FGFR3 remains unclear. Here, we determine the effect of statins on FGFR signaling in chondrocytes.
    Design: Cultured chondrocyte cell lines, mouse embryonic tibia cultures and limb bud micromasses were treated with FGF2 to activate FGFR signaling. The effects of atorvastatin, fluvastatin, lovastatin and pravastatin on FGFR3 protein stability and on FGFR-mediated chondrocyte growth-arrest, loss of extracellular matrix (ECM), induction of premature senescence and hypertrophic differentiation were evaluated.
    Results: Statins did not alter the level of FGFR3 protein expression nor produce any effect on FGFR-mediated inhibition of chondrocyte proliferation and hypertrophic differentiation in cultured chondrocyte cell lines, mouse tibia cultures or limb bud micromasses.
    Conclusion: We conclude that statins do not inhibit the FGFR signaling in chondrocytes. Therefore the statin-mediated rescue of FGFR3-related chondrodysplasia, described before, is likely not intrinsic to the growth plate cartilage.
    PracovištěÚstav živočišné fyziologie a genetiky
    KontaktJana Zásmětová, knihovna@iapg.cas.cz, Tel.: 315 639 554
    Rok sběru2018
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.